Tag: Biotechnology
-
Continuous Genome Editing Assessment: A Key to Africa’s Agricultural Progress
Overview: Why continuous assessment matters Africa’s agricultural sector stands at a pivotal crossroads. With the continent needing to feed a growing population while confronting climate change, continuous genome editing assessment emerges as a practical tool to improve crop resilience, yield, and nutritional quality. Professor Olalekan Akinbo, head of the Genome Editing Programme at the African…
-
New Fluorescent Markers Reveal Dynamic Cell-to-Cell Communication
New Fluorescent Markers Illuminate How Cells Talk Cells in living organisms constantly exchange information to coordinate growth, response to stress, and tissue maintenance. Understanding the precise timing and manner of these interactions has long been a challenge for scientists. A team of researchers from Japan has developed a novel set of fluorescent markers that allows…
-
Google DeepMind unveils AlphaGenome to map genetic drivers of disease
Overview: A new AI tool for genetic insights Google DeepMind has introduced AlphaGenome, a pioneering artificial intelligence tool designed to help scientists identify the genetic drivers of disease. By focusing on how specific genetic mutations influence disease pathways, the platform aims to accelerate research, reduce time to discovery, and open new avenues for targeted therapies.…
-
AI-Designed Virus: How Lab-Grown Life Is Pushing Boundaries
Overview: A Breakthrough that Sparks Debate The new era of lab-grown life is under intense scrutiny as researchers report the creation of a virus dubbed Evo-Φ2147, engineered with artificial intelligence and from-scratch design. Proponents say the approach could accelerate understanding of viral behavior, inform vaccine development, and reveal new biological principles. Critics warn that such…
-
HanchorBio WuXi Biologics Partnership Advances Proteins
Strategic Partnership Expands Next-Generation Fusion Protein Pipeline HanchorBio, a global clinical-stage biotechnology company focused on next-generation immunotherapies, and WuXi Biologics, a leading contract development and manufacturing organization for biologics, announced a strategic collaboration to accelerate the development of next-generation bifunctional fusion proteins. The alliance aims to advance a robust pipeline targeting oncology and autoimmune diseases,…
-
HanchorBio and WuXi Biologics Forge Strategic Partnership to Accelerate Next-Gen Bi- and Multi-Functional Fusion Protein Pipeline
Strategic Partnership Aims to Accelerate Next-Generation Fusion Protein Programs HanchorBio, Inc., a global clinical-stage biotechnology company focused on next-generation immunotherapies for oncology and autoimmune diseases, and WuXi Biologics, a leading global biopharmaceutical development and manufacturing services provider, today announced a strategic partnership to advance a next-generation bi- and multi-functional fusion protein pipeline. This collaboration is…
-
Health Canada Rules Gene-Edited Pigs Safe to Eat for Consumption
Health Canada Confirms Safety of Gene-Edited Pork In a landmark assessment, Health Canada announced that meat from pigs engineered to resist porcine reproductive and respiratory syndrome (PRRS) is safe for Canadian consumers. The decision follows a rigorous review of genetic modification techniques, animal health data, and nutritional equivalence to traditional pork. Regulators emphasize that the…
-
Customizable Protein Platforms Offer New Hope for Cancer Treatment
Revolutionizing cancer therapy with customizable protein platforms Researchers at the University of Massachusetts Amherst are advancing a transformative approach to cancer treatment: customizable protein platforms designed to precisely shred, repair, or replace cancer-causing proteins within malignant cells. This breakthrough aims to disrupt the very proteins that drive tumor growth, potentially offering therapies that are more…
-
D3 Bio Secures FDA Clearance for Two INDs, Jumpstarting Phase 1 and Phase 2 Trials
FDA Clears Two INDs for D3 Bio, Launching Key Clinical Trials Shanghai-based D3 Bio, a clinical-stage biotechnology company focused on transformative oncology therapies, has announced that the U.S. Food and Drug Administration (FDA) has cleared two Investigational New Drug (IND) applications. The approvals enable a Phase 1 clinical trial for D3S-003 and a Phase 2…
-
Genetically Modified Mosquitoes Block Malaria in Tanzania
Groundbreaking Step in Malaria Control In a landmark development, researchers in Tanzania have created genetically modified mosquitoes that hinder the malaria parasite from completing its life cycle. By introducing naturally occurring molecules from frogs and bees into the mosquitoes, the team aims to stop Plasmodium parasites from developing inside the vector, potentially reducing transmission to…